[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 105
Citations 0
Correction
August 2019

Error in Title

JAMA Oncol. 2019;5(8):1232. doi:10.1001/jamaoncol.2019.3304

In the Original Investigation titled, “Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate,” which published online June 27, 2019, in JAMA Oncology,1 there was an error in the title. The correct title is “Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.” This article was corrected online.

References
1.
Attard  G, Merseburger  AS, Wiebke  A,  et al.  Assessment of the safety of glucocorticoid regimens in combination with abiraterone acetate for metastatic castration-resistant prostate cancer  [published online June 27, 2019].  JAMA Oncol. doi:10.1001/jamaoncol.2019.1011Google Scholar
×